Mai Nguyen-Huynh to Fibrinolytic Agents
This is a "connection" page, showing publications Mai Nguyen-Huynh has written about Fibrinolytic Agents.
Connection Strength
1.501
-
Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment. Stroke. 2020 09; 51(9):2697-2704.
Score: 0.718
-
Is hospitalization after TIA cost-effective on the basis of treatment with tPA? Neurology. 2005 Dec 13; 65(11):1799-801.
Score: 0.260
-
Response by Flint et al to Letter Regarding Article, "Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment". Stroke. 2021 01; 52(1):e39-e40.
Score: 0.184
-
Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e601S-e636S.
Score: 0.099
-
Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke. 2011 Jun; 42(6):1658-64.
Score: 0.094
-
Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: a consecutive cross-sectional survey. Clin Exp Pharmacol Physiol. 2010 Aug; 37(8):775-81.
Score: 0.088
-
Comparative safety of tenecteplase vs alteplase for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2024 Jan; 33(1):107468.
Score: 0.056